Skip to main content
Interpace Biosciences, Inc. (IDXG)
OTCMKTS · Delayed Price · Currency is USD
0.7000
+0.0200 (2.94%)
May 6, 2025, 10:06 AM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Diagnostic Clinical Services
40.21M
Log In
Log In
Log In
Log In
Diagnostic Clinical Services Growth
26.31%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
United States
40.21M
Log In
Log In
Log In
Log In
United States Growth
26.31%
Log In
Log In
Log In
Log In